Tag: clinical pathology lab

September 26, 2016 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

Molecular and genetic testing laboratories that use the Microsoft Excel software program for some of their homegrown informatics may be at risk of lab testing errors due to an auto-correct quirk in the Exel software. Modern Healthcare reported on how researchers in Australia looked at 3,600 genetics papers. They determined that use of Microsoft Excel was

View Article

December 7, 2015 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

Last week, a joint laboratory accreditation agreement was announced by AABB and the American Association for Laboratory Accreditation (A2LA). The two associations will now collaborate to allow labs to obtain three assessments under one effort, including AABB accreditation, ISO 15189 accreditation, and CLIA requirements. In their statement about the benefits of the new arrangement, the

View Article

May 28, 2013 “Intelligence: Late Breaking Lab News””

Globalization of laboratory medicine continues to move forward. Two recent examples illustrate this trend. Earlier this month, the University of Pittsburgh Medical Center (UPMC) announced that it had entered into an agreement with the Citizens Hospital of Hyderabad, India, to form a clinical pathology laboratory in that city. The laboratory will be located on the

View Article

October 8, 2012 “Intelligence: Late Breaking Lab News”

Definiens AG, one of the major players in the fast-growing market for digital pathology, raised $12.8 million in additional capital funding. The company, based in Munich, Germany, manufacturers systems for digital image analysis. Definiens stated that the new funds will be used for “commercial expansion of its current business and to develop and commercialize innovative

View Article

Sonic Healthcare Acquires Labs from Aussie Competitor

LABORATORY CONSOLIDATION continues in Australia with news that Sonic Healthcare Limited of Sydney, Australia, has agreed to acquire three clinical laboratory business units from competitor Healthscope, Ltd., of Melbourne, Australia.

The acquisition was announced on May 16. In three separate transactions, Sonic will pay A$100 million (US$99.4 million) for the Healthscope pathology operations in Queensland, Australian

View Article

Payers Move to Pre-Authorize Expensive Genetic Tests

CEO Summary: Pre-authorization of expensive genetic and molecular tests is fast-becoming a priority for most of the nation’s health insurers. For clinical labs and pathology groups that don’t respond, this trend is a threat. On the other hand, because payers need all the skills and knowledge that labs possess to intelligently manage utilization of molecular

View Article